Founded in 1998, as a company dedicated to making emerging minimally invasive technologies more accessible to more patients across the world. Today, MicroPort® is a leading provider of cardiovascular therapeutic solutions.

Healthcare Professionals Cardiovascular

Percutaneous Coronary Intervention

Within two decades, MicroPort® has transformed itself from a market follower, into a global leader in the field of Percutaneous Coronary Intervention (PCI). Its proprietary Firehawk® targeted eluting stent system, with proven clinical evidence in terms of safety and efficacy, has become a leading stent, setting industry standards for a new generation of global cardiac stents.

Click here to know more
Cardiovascular FIREHAWK 1

Transcatheter Aortic Valve Replacement

MicroPort®’s Vitaflow® Aortic Valve, uses bovine pericardial leaflets to provide enhanced valve durability, its innovative frame and skirt designs deliver reliable hemodynamic performance, and dependable clinical outcomes for patients. Since launch, MicroPort®’s TAVR solution is fast becoming the leading therapeutic solution to treat aortic valve disease within China, and is currently expanding to more markets across the globe.

Click here to know more
Cardiovascular Vitaflow 2